PHILADELPHIA, April 3,
2024 /PRNewswire/ -- Carisma Therapeutics
Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a
clinical-stage biopharmaceutical company focused on discovering and
developing innovative immunotherapies, today announced that it will
present at the following upcoming conferences:
Needham 23rd Annual Virtual Healthcare
Conference
- Steven Kelly, President and
Chief Executive Officer, will give a corporate presentation.
- Wednesday, April 10 at
3:45 PM ET
- Virtual
Chardan 8th Annual Genetic Medicines & Cell
Therapy Manufacturing Summit
- Steven Kelly, President and
Chief Executive Officer, will give a corporate presentation.
- Monday, April 29 at 2:00 PM ET
- Virtual
Live webcasts will be available on the Company's Investor Events
webpage. A replay of the webcasts, when available, will be archived
for a limited time following each event.
About Carisma
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical
company focused on utilizing our proprietary macrophage and
monocyte cell engineering platform to develop transformative
immunotherapies to treat cancer and other serious diseases. We have
created a comprehensive, differentiated proprietary cell therapy
platform focused on engineered macrophages and monocytes, cells
that play a crucial role in both the innate and adaptive immune
response. Carisma is headquartered in Philadelphia, PA. For more information, please
visit www.carismatx.com.
Investors:
Shveta
Dighe
Head of Investor Relations
investors@carismatx.com
Media Contact:
Julia
Stern
(763) 350-5223
jstern@realchemistry.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-upcoming-conferences-302106448.html
SOURCE Carisma Therapeutics Inc.